USPTO serial 98206800
INDIVUTEST
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- JOHNSON, CLINTON J
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INDIVUTEST?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
R. Glenn Schroeder
R. Glenn Schroeder SCHROEDER LAW PC110 COOPER STREET #605BABYLON, NY 11702United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods for clinical and laboratory use in the nature of Diagnostic preparations, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations, in particular medicines for human beings and animals, namely, pharmaceutical and veterinary preparations for the treatment of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; human and animal sample material, namely, allograft and xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool, all in nature of cell culture medium for medical use; test kits for human and animal sample material, namely, allograft and xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool, all in the nature of diagnostic test kits comprised of medical diagnostic reagents and assays for testing of human sample material, namely, allograft and xenograft tissue preparations in culture medium for medical use for disease detection, namely, cancer and therapeutic decision making in the field of oncology; diagnostic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods for medical use; therapeutic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods in the nature of therapeutic medicated bath preparations | ACTIVE | — |
| 009 | Electronic apparatus and instruments for scientific laboratory research, namely, electronic analyzers and analyzers for the qualitative and quantitative recognition of samples and identification of the sample type; scientific electronic apparatus for the typing of tissue and tissue samples and tissue cuts; apparatus for recording, transmission or reproduction of data; blank magnetic data carriers; data processing equipment; computers | ACTIVE | — |
| 042 | Scientific research; design and development of new technology for others in the field of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; analysis of industrial fluids and industrial research in the field of oncology; design and development of computer hardware and software, in particular computer programs; scientific research for medical purposes, in particular molecular biological, immunological and histological laboratory services, in particular scientific research and development in the field of human medical and veterinary medical diagnostics and therapy; scientific research for medical purposes in the field of genetic engineering; research and development services in the field of oncology diagnostics; diagnostic services using standard laboratory equipment for scientific cancer research services purposes; providing diagnostic services for others for scientific research services purposes related to the generation of complex data and data sets obtained by multi-omics analysis of human and animal samples, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human urine and human stool, and provision of such data and data sets in whole or in part, unprocessed or processed, to patients, scientists, physicians, medical institutions or scientific institutions, all in the field of oncology for supporting diagnosis and treatment efforts; generation of complex data and data sets by multi-omics analysis of human and animal sample material, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human urine and human stool, all being biologic analysis scientific research services for the support of oncology diagnosis and treatment; diagnostic services related to generated and/or analysed complex data and data sets received through multi-omics analysis of human and animal sample material, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human urine and human stool, all being scientific research provided for the support of oncology diagnosis and treatment | ACTIVE | — |
| 044 | Medical analyses in connection with the treatment of individuals including X-rays and blood samples, namely, medical testing for diagnostic and treatment purposes in the field of cancer; medical clinic services; pharmaceutical advisory services for providing support for pharmaceutical and other treatment advice for oncology patients; medical diagnostic testing, monitoring and reporting services; tissue typing services by means of molecular biological, immunological, and histological methods; generation of complex data and data sets by multi-omics analysis of human and animal sample material, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool, all being body composition analysis services for medical purposes; diagnostic services related to generated and/or analysed complex data and data sets received through multi-omics analysis of human and animal sample material, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool, all being medical diagnostic services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by IndivuTest GmbH
- Other trademarks owned by IndivuTest GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named INDIVUTEST
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 16, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 16, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 15, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 20, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 20, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 14, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 22, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 22, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 22, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 22, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 25, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 25, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 25, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 3, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 3, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 3, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Aug 21, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jun 4, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 22, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 12, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 5, 2023 | NWAP | NEW APPLICATION ENTERED | — |